What is Retatrutide?

The compound and its code

Retatrutide is the assigned name for the peptide developed under the code LY3437943. Both names refer to the same molecule, and vendor listings use them interchangeably. If you see one on a label and the other on an invoice, that is a naming difference, not a product difference.

DoseGraph files Retatrutide under metabolic peptides. That is a filing category, not a description of what it does in a body. This site carries no medical review, so it cannot answer clinical questions about the compound. Those belong to a doctor who can see you and your history. What this page can do is arithmetic, which is either correct or it is not.

Regulatory status

Retatrutide is not approved by any regulator for human use. There is no approved label, which means no approved dose, no approved schedule, no approved route and no vetted warnings. Everything printed on a vendor product page was written by the seller.

This matters for how you read numbers you find. The amounts that appear in listings, commonly 1, 2, 4, 8 and 12 mg, are marketing copy describing how sellers expect stock to be split. They are not a prescribing range and nothing here endorses them. Material sold without approval also has no enforced identity or purity standard. The arithmetic below assumes the vial contains the mass printed on it, which is an assumption arithmetic cannot verify.

Reading the concentration table

The table on this page crosses five vial sizes, 5 through 30 mg, with four bacteriostatic water volumes, 1 through 3 mL. Every cell is vial mass divided by water volume, in mg/mL. Nothing else is involved.

Three things are worth pulling out. First, the same concentration appears in several places. A 5 mg vial in 1 mL, a 10 mg vial in 2 mL and a 15 mg vial in 3 mL all land on 5 mg/mL. The vials hold different total amounts, but each millilitre of finished solution is identical. Total content and concentration are separate properties, and confusing them is the most common source of error.

Second, the spread is large. The weakest cell is a 5 mg vial in 3 mL at 1.67 mg/mL. The strongest is a 30 mg vial in 1 mL at 30 mg/mL. Both look like clear liquid. That is why the water volume has to be recorded and kept with the vial.

Third, round numbers cluster at particular pairings. A 10 mg vial in 1 mL, a 20 mg vial in 2 mL and a 30 mg vial in 3 mL all give 10 mg/mL. Whole-number concentrations are easier to check by eye than values like 1.67 or 3.33 mg/mL.

Water volume, and what the site models

Vial mass is fixed when you buy it. Water volume is chosen at reconstitution, and once chosen it fixes the concentration until the vial is finished. There is no correcting it afterward. Adding more water does not change how much peptide you have: a 30 mg vial holds 30 mg whether it is reconstituted in 1 mL or 3 mL, giving 30 mg/mL or 10 mg/mL respectively. Larger volumes make small measurements easier to read. Smaller volumes reduce injection volume. That tradeoff is the whole decision.

Label the vial with the water volume you used, in ink, at the time you use it. Reconstruction from memory a week later is how people end up guessing, and a guessed water volume makes every later calculation wrong by a factor nobody can recover.

Retatrutide is modelled end to end here. Half life, absorption, accumulation across repeated administration and clearance after stopping are all computed on their own pages. A model is not advice. Those curves show what follows arithmetically from an input, not whether that input is sensible for you. DoseGraph divides milligrams by millilitres and stops there.

What we do not know

Retatrutide is modelled end to end on this site: half life, absorption, accumulation and clearance are all computed.

This page answers arithmetic and handling questions. It does not tell you what dose to take, what to expect, or whether anything is appropriate for you, and there is no medical review behind it.

Common questions

Is Retatrutide approved?

No. Retatrutide is not approved by any regulator for human use. There is no approved label, so there is no official dose, schedule or set of warnings. Anything presented as a standard protocol was written by a seller or a forum, not a regulator.

Is Retatrutide the same as LY3437943?

Yes. LY3437943 is the development code and Retatrutide is the assigned name for the same peptide. Vendors use both, sometimes on the same product. A different name on the label and the invoice does not by itself indicate a different compound.

How much water should I add to my vial?

There is no single correct answer, because water volume is a measuring convenience rather than a property of the peptide. The table on this page shows what each of 1, 2, 2.5 and 3 mL produces for every vial size sold. Larger volumes make small measurements easier to read; smaller volumes reduce injection volume.

Does adding more water reduce the dose?

It reduces the concentration, not the total amount in the vial. A 10 mg vial contains 10 mg whether it is reconstituted in 1 mL, giving 10 mg/mL, or in 2 mL, giving 5 mg/mL. You draw a larger volume from the weaker solution to move the same mass.

What dose of Retatrutide should I take?

This site will not answer that. There is no approved label to reference and no medical review behind these pages, so any figure given here would be invented. The amounts in vendor listings describe how sellers expect stock to be split, not a recommended range. Ask a doctor.

Why do different vials give the same concentration?

Because concentration is mass divided by volume, and different pairs of inputs can divide to the same result. A 5 mg vial in 1 mL, a 10 mg vial in 2 mL and a 15 mg vial in 3 mL all give 5 mg/mL. Each millilitre is identical; the vials just run out at different points.